Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Foreign exchange gain (loss) [abstract]
Foreign exchange gain (loss)
626,240 GBP
1,485 GBP
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
3,372,512 GBP
3,936,279 GBP
Current assets
839,048 GBP
2,169,614 GBP
Non-current liabilities
2,199,413 GBP
2,583,364 GBP
Current liabilities
1,158,653 GBP
741,523 GBP
Revenue
- GBP
- GBP
Profit (loss)
- GBP
- GBP
- GBP
5,619,181 GBP
6,297 GBP
5,625,478 GBP
- GBP
- GBP
- GBP
6,696,493 GBP
- GBP
5,815 GBP
6,690,678 GBP
- GBP
- GBP
- GBP
- GBP
- GBP
Other comprehensive income
- GBP
- GBP
- GBP
- GBP
- GBP
358,396 GBP
- GBP
358,459 GBP
- GBP
903,067 GBP
- GBP
- GBP
- GBP
- GBP
- GBP
903,067 GBP
- GBP
- GBP
Comprehensive income
- GBP
- GBP
- GBP
- GBP
5,983,937 GBP
- GBP
358,459 GBP
- GBP
5,793,426 GBP
- GBP
- GBP
- GBP
- GBP
903,067 GBP
- GBP
- GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.